Bernadette Johnson

524 total citations
15 papers, 406 citations indexed

About

Bernadette Johnson is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Bernadette Johnson has authored 15 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Bernadette Johnson's work include Prostate Cancer Treatment and Research (7 papers), Medical Imaging Techniques and Applications (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Bernadette Johnson is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Medical Imaging Techniques and Applications (5 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Bernadette Johnson collaborates with scholars based in United Kingdom, Sweden and Japan. Bernadette Johnson's co-authors include Valerie Lewington, Chris Parker, David P. Dearnaley, Sarah Chittenden, Glenn Flux, Sue Chua, Gary Cook, Anne-Kirsti Aksnes, B. Pratt and Christopher Parker and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Physics in Medicine and Biology.

In The Last Decade

Bernadette Johnson

15 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernadette Johnson United Kingdom 10 199 197 142 72 64 15 406
C. Maschi France 15 141 0.7× 112 0.6× 201 1.4× 83 1.2× 63 1.0× 47 661
Ligang Xing China 13 241 1.2× 284 1.4× 169 1.2× 88 1.2× 62 1.0× 44 594
Masahiko Taguchi Japan 9 71 0.4× 263 1.3× 137 1.0× 55 0.8× 46 0.7× 25 429
Kobe Reynders Netherlands 7 94 0.5× 217 1.1× 388 2.7× 60 0.8× 164 2.6× 12 550
Olarn Roengvoraphoj Germany 14 152 0.8× 305 1.5× 243 1.7× 37 0.5× 18 0.3× 34 476
Konstantin Lavrenkov Israel 12 126 0.6× 160 0.8× 150 1.1× 76 1.1× 17 0.3× 29 416
Rafael Martìnez Monge Spain 6 61 0.3× 125 0.6× 176 1.2× 51 0.7× 70 1.1× 13 345
S Finn United States 6 83 0.4× 66 0.3× 145 1.0× 97 1.3× 56 0.9× 8 409
Daniele Scartoni Italy 9 110 0.6× 212 1.1× 76 0.5× 44 0.6× 26 0.4× 45 351
L. Gogou Greece 9 202 1.0× 65 0.3× 127 0.9× 44 0.6× 20 0.3× 13 417

Countries citing papers authored by Bernadette Johnson

Since Specialization
Citations

This map shows the geographic impact of Bernadette Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernadette Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernadette Johnson more than expected).

Fields of papers citing papers by Bernadette Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernadette Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernadette Johnson. The network helps show where Bernadette Johnson may publish in the future.

Co-authorship network of co-authors of Bernadette Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Bernadette Johnson. A scholar is included among the top collaborators of Bernadette Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernadette Johnson. Bernadette Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Crabb, Simon J., Sarah Danson, James W.F. Catto, et al.. (2021). Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE). Clinical Cancer Research. 27(7). 1882–1892. 17 indexed citations
2.
Denis-Bacelar, Ana M., Sarah Chittenden, V. R. McCready, et al.. (2018). Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy. British Journal of Radiology. 91(1084). 20170795–20170795. 11 indexed citations
3.
Parker, Chris, Roberto Alonzi, Nina Tunariu, et al.. (2018). Radium-223: Disease response and fracture assessment by whole body diffusion-weighted MRI (WB-DWMRI) in metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 36(15_suppl). 5024–5024. 2 indexed citations
4.
Denis-Bacelar, Ana M., Sarah Chittenden, Iain Murray, et al.. (2017). A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases. Physics in Medicine and Biology. 62(7). 2859–2870. 5 indexed citations
5.
Mehra, Niven, Adam Sharp, David Lorente, et al.. (2017). Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral Corticosteroids. Clinical Genitourinary Cancer. 15(6). 678–684.e1. 16 indexed citations
6.
Denis-Bacelar, Ana M., Sarah Chittenden, David P. Dearnaley, et al.. (2016). Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival. European Journal of Nuclear Medicine and Molecular Imaging. 44(4). 620–629. 16 indexed citations
7.
Chittenden, Sarah, Cécilia Hindorf, Christopher Parker, et al.. (2015). A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases. Journal of Nuclear Medicine. 56(9). 1304–1309. 85 indexed citations
8.
Chudley, Lindsey, Katy J. McCann, Ann Mander, et al.. (2012). DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time. Cancer Immunology Immunotherapy. 61(11). 2161–2170. 77 indexed citations
9.
10.
Holen, Kyle D., E. Heath, William R. Schelman, et al.. (2010). Phase I first-in-human study of the centromere-associated protein E (CENP-E) inhibitor GSK923295 in patients with advanced solid tumors (study CPE107602).. Journal of Clinical Oncology. 28(15_suppl). 3012–3012. 2 indexed citations
11.
Murthy, Vedang, Karen Thomas, Kerwyn Foo, et al.. (2008). Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy in Advanced Lymphoma: A Phase II Study. Clinical Lymphoma & Myeloma. 8(4). 241–245. 37 indexed citations
12.
Fleming, Ronald A., Kyle D. Holen, Bernadette Johnson, et al.. (2008). 397 POSTER A phase I dose escalation and pharmacokinetic study of the novel mitotic checkpoint inhibitor GSK923295A in patients with solid tumors. European Journal of Cancer Supplements. 6(12). 125–125. 1 indexed citations
13.
Venkitaraman, Ramachandran, Bernadette Johnson, Robert Huddart, et al.. (2007). The utility of lactate dehydrogenase in the follow‐up of testicular germ cell tumours. British Journal of Urology. 100(1). 30–32. 32 indexed citations
14.
15.
Ryan, D. P., J. P. Eder, Leonard J. Appleman, et al.. (2005). A phase I study of E7070, a chloroindolyl-sulfonamide, in combination with irinotecan in gastrointestinal and thoracic carcinomas. Journal of Clinical Oncology. 23(16_suppl). 2031–2031. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Maschi Breakdown of academic impact, for papers by Ligang Xing Breakdown of academic impact, for papers by Masahiko Taguchi Breakdown of academic impact, for papers by Kobe Reynders Breakdown of academic impact, for papers by Olarn Roengvoraphoj Breakdown of academic impact, for papers by Konstantin Lavrenkov Breakdown of academic impact, for papers by Rafael Martìnez Monge Breakdown of academic impact, for papers by S Finn Breakdown of academic impact, for papers by Daniele Scartoni Breakdown of academic impact, for papers by L. Gogou
Rankless by CCL
2026